Hypertension treatment may reduce risk of dementia

People over the age of 60 who are treated for their high blood pressure (hypertension) have a 26% lower risk of dementia compared to those who are untreated, according to research from UNSW Sydney’s Centre for Healthy Brain Ageing (CHeBA).

The study, published in JAMA Network Open, highlighted that dementia risk was substantially reduced in the treated hypertension group throughout late life. The study is the largest of its kind to date, utilising data from 34,519 individuals across 15 different countries.

Dementia poses a burgeoning worldwide challenge with approximately 57 million people currently living with dementia and an anticipated 153 million by the year 2050. Hypertension is the most prevalent risk factor for dementia, affecting more than 1 billion people worldwide.

Dr Matt Lennon, a medical doctor and lead author on the study, said the findings were critical for general practitioners and family physicians, who are most commonly at the coal face of blood pressure management.

“We know that mid-life hypertension increases risk of all types of dementia by around 60%, and Alzheimer’s disease by 25%,” says Dr Lennon.

“However, in late-life (i.e. those older than 60) studies have variously found high blood pressure to increase, not affect or decrease dementia risk. This lack of clarity is deeply problematic.”

Dr Lennon explained that in this study the international research team clarified ambiguities in the field.

According to Dr Lennon, the findings will have an impact on blood pressure management guidelines and will change parts of the academic conversation around blood pressure.

“This study provides responses to critical questions for public health,” says Dr Lennon.

The study identified that in late life people with unmedicated hypertension have a significantly elevated risk of dementia compared to those with medicated hypertension and healthy individuals.

Co-Director of CHeBA and co-author on the research, Professor Perminder Sachdev, said that, “the findings indicate that ongoing antihypertensive therapy throughout late life is an important part of dementia prevention.”